B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014

Mar 2014 GlobalData Lymphoma203 Pages Price :
$ 2500
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014\" provides data on the B-Cell Non-Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Non-Hodgkin Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData\'s team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 5
Introduction 6
B-Cell Non-Hodgkin Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of B-Cell Non-Hodgkin Lymphoma 25
Subjects Recruited Over a Period of Time 37
Clinical Trials by Sponsor Type 38
Prominent Sponsors 39
Top Companies Participating in B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials 40
Prominent Drugs 42
Latest Clinical Trials News on B-Cell Non-Hodgkin Lymphoma 43
Dec 04, 2013: Completion of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma 43
Jun 17, 2013: Cell Therapeutics Announces Results From Sub-set Analyses Of Data From Phase III EXTEND Clinical Trial Of Pixuvri 43
May 06, 2013: Senesco Gets DRC Approval To Initiate Cohort 3 In Phase Ib/IIa Study In Multiple Myeloma And Non-Hodgkins B-Cell Lymphoma 44
Feb 11, 2013: TG Therapeutics Opens Expansion Cohorts In Phase I/II Trial Of TG-1101 In Patients With Rituximab Relapsed Or Refractory B-cell Non-Hodgkin\'s Lymphoma 45
Feb 06, 2013: Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A 46
Clinical Trial Profiles 47
Clinical Trial Overview of Top Companies 47
F. Hoffmann-La Roche Ltd. 47
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 47
Celgene Corporation 54
Clinical Trial Overview of Celgene Corporation 54
Takeda Pharmaceutical Company Limited 58
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 58
GlaxoSmithKline plc 61
Clinical Trial Overview of GlaxoSmithKline plc 61
Amgen Inc. 64
Clinical Trial Overview of Amgen Inc. 64
Novartis AG 67
Clinical Trial Overview of Novartis AG 67
Pharmacyclics, Inc. 70
Clinical Trial Overview of Pharmacyclics, Inc. 70
Pfizer Inc. 73
Clinical Trial Overview of Pfizer Inc. 73
Biogen Idec Inc. 76
Clinical Trial Overview of Biogen Idec Inc. 76
Immunomedics, Inc. 79
Clinical Trial Overview of Immunomedics, Inc. 79
Clinical Trial Overview of Top Institutes / Government 81
National Cancer Institute 81
Clinical Trial Overview of National Cancer Institute 81
Fred Hutchinson Cancer Research Center 92
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 92
The University of Texas M. D. Anderson Cancer Center 97
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 97
Memorial Sloan Kettering Cancer Center 100
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 100
Mayo Clinic 102
Clinical Trial Overview of Mayo Clinic 102
Southwest Oncology Group 104
Clinical Trial Overview of Southwest Oncology Group 104
Groupe d\'Etudes de Lymphomes de L\'Adulte 106
Clinical Trial Overview of Groupe d\'Etudes de Lymphomes de L\'Adulte 106
City of Hope National Medical Center 108
Clinical Trial Overview of City of Hope National Medical Center 108
Stanford University 110
Clinical Trial Overview of Stanford University 110
Five Key Clinical Profiles 111

Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203

List of Table


B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Terminated Clinical Trials, 2014* 28
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 37
B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 38
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 39
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 41
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 42
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 47
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 54
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 58
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 61
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 64
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 67
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2014* 70
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 73
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 76
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2014* 79
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 81
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014* 92
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 97
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 100
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 102
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2014* 104
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe d\'Etudes de Lymphomes de L\'Adulte, 2014* 106
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2014* 108
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 110

List of Chart


B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
B-Cell Non-Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of B-Cell Non-Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
B-Cell Non-Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
B-Cell Non-Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 37
B-Cell Non-Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 38
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 39
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 40
B-Cell Non-Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 42
GlobalData Methodology 201

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 2500
$ 5000

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top